About Strata Skin Sciences, Inc. - Common Stock (SSKN)
Strata Skin Sciences is a medical technology company dedicated to the development and commercialization of innovative solutions for the treatment of various skin conditions, particularly focused on dermatological therapies and aesthetic treatments. The company utilizes advanced technologies to create products that enhance the effectiveness of dermatological treatments, aiming to improve patient outcomes and satisfaction. Through its research and development efforts, Strata Skin Sciences is committed to addressing unmet medical needs in skincare and providing healthcare professionals with effective tools for managing skin diseases and aesthetic concerns. Read More
Roadzen Inc. (NASDAQ: RDZN), a global AI leader at the intersection of insurance and mobility, announced it has secured a major mandate exceeding $20 million in annual gross written premiums from one of the world’s top five carmakers . Under the agreement, Roadzen will serve as a Managing General Agent (MGA), managing administration, claims, and payments for the automaker’s insurance operations in a major European market.
Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday's regular session. The market value of their outstanding shares is at $3.6 million.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Peraso Inc. (NASDAQ: PRSO), a pioneer in mmWave wireless technology solutions, announced it has regained compliance with the Nasdaq Capital Market’s minimum bid price requirement. The notice from Nasdaq follows the company’s recent momentum in fixed wireless access (FWA), defense communications, transportation, and professional communication markets.
STRATA Skin Sciences Inc. (NASDAQ: SSKN) witnessed a dramatic surge in its stock price today, climbing 51.18% following the publication of a groundbreaking peer-reviewed study. The research highlights the superior efficacy and safety of its 308nm Excimer laser, specifically the XTRAC® system, when combined with Janus Kinase (JAK) inhibitors
Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Wondering how the US markets performed in the middle of the day on Wednesday? Discover the movers and shakers of today's session in our comprehensive analysis.
